EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Evidence‐based consensus guidelines for ALS genetic testing and counseling

Jennifer Roggenbuck iD, Breda H F Eubank, Joshua Wright, Matthew B Harms, Stephen J Kolb, ALS Genetic Testing and Counseling Guidelines Expert Panel

Annals of Clinical and Translational Neurology · 2023-11 · 10 (11) · 2074-2091

DOI: 10.1002/acn3.51895 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 10.09.2023. Verfasst von Jennifer Roggenbuck und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Genetics, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amyotrophic Lateral Sclerosis Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Advances in amyotrophic lateral sclerosis (ALS) gene discovery, ongoing gene therapy trials, and patient demand have driven increased use of ALS genetic testing. Despite this progress, the offer of genetic testing to persons with ALS is not yet “standard of care.” Our primary goal is to develop clinical ALS genetic counseling and testing guidelines to improve and standardize genetic counseling and testing practice among neurologists, genetic counselors or any provider caring for persons with ALS.

Methods

Core clinical questions were identified and a rapid review performed according to Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA‐P) 2015 method. Guideline recommendations were drafted and the strength of evidence for each recommendation was assessed by combining two systems: the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) System and the Evaluation of Genomic Applications in Practice and Prevention (EGAPP). A modified Delphi approach was used to reach consensus among a group of content experts for each guideline statement.

Results

A total of 35 guideline statements were developed. In summary, all persons with ALS should be offered single‐step genetic testing, consisting of a C9orf72 assay, along with sequencing of SOD1, FUS, and TARDBP, at a minimum. The key education and genetic risk assessments that should be provided before and after testing are delineated. Specific guidance regarding testing methods and reporting for C9orf72 and other genes is provided for commercial laboratories.

Interpretation

These evidence‐based, consensus guidelines will support all stakeholders in the ALS community in navigating benefits and challenges of genetic testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisHumansC9orf72 ProteinSystematic Reviews as TopicMeta-Analysis as TopicGenetic TestingCounseling

Substanzen

C9orf72 Protein

Autor:innen und Institutionen

  • Division of Human Genetics, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Health & Physical Education Department, Faculty of Health, Community, & Education, Mount Royal University, 4825 Mount Royal Gate SW, Calgary, Alberta, Canada.
  • Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
  • Department of Biological Chemistry & Pharmacology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.

ORCID-Profile: Jennifer Roggenbuck

Förderung

  • Amyotrophic Lateral Sclerosis Association

Zitieren

APA

Roggenbuck, J., Eubank, B. H. F., Wright, J., Harms, M. B., Kolb, S. J., & ALS Genetic Testing and Counseling Guidelines Expert Panel (2023). Evidence‐based consensus guidelines for ALS genetic testing and counseling. Annals of Clinical and Translational Neurology, 10(11), 2074-2091. https://doi.org/10.1002/acn3.51895

Vancouver

Roggenbuck J, Eubank BHF, Wright J, Harms MB, Kolb SJ, ALS Genetic Testing and Counseling Guidelines Expert Panel. Evidence‐based consensus guidelines for ALS genetic testing and counseling. Annals of Clinical and Translational Neurology. 2023;10(11):2074-2091. doi:10.1002/acn3.51895

BibTeX
@article{Roggenbuck2023,
  author = {Roggenbuck, Jennifer and Eubank, Breda H F and Wright, Joshua and Harms, Matthew B and Kolb, Stephen J and ALS Genetic Testing and Counseling Guidelines Expert Panel, ALS Genetic Testing and Counseling Guidelines Expert Panel},
  title = {Evidence‐based consensus guidelines for ALS genetic testing and counseling},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2023},
  volume = {10},
  number = {11},
  pages = {2074--2091},
  doi = {10.1002/acn3.51895}
}
Kostenlos starten →